Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am watching level two....Cantor doing just fine...the selling is coming out of NITE....I guessing that makes you Network One...am I correct?
80 subjects in PII study....average amount....it is a PII study not a PIII. This drug costs less than a quarter per dose.....they will likely charge $10,000-$20,000 per treatment. It's all profit. Burn rate on cash not a problem now....there is a pending license deal that will put over $50mm in the bank. BTD decision could be anyday.
And you want to short this?
Knock yourself out....I got my chair and popcorn....waiting to watch this.
The rapid rise up was done by the same group. They made money suckering the momentum traders in then shorted it down. They came out of Toronto, Canada....I know who they are. If you are a short trader by nature....well that's fine....I would not suggest it at this moment but do what you do best. Cantor Fitzgerald likely will absorb most of it as they now have an interest in maintaining stability. Good luck.
That rise and fall was a bear raid out of Toronto.
The best executed one I ever saw.
They got 18mm in the bank
We all know the history... Where were you?
You will short because you can.... Fair enough
Many here will average down thanks to you
And that's not a bad thing for the strong hands
The weak need to go anyway
Better read the tech on the blog before you do!
New blog up!
To all shorters:
Knock yourself out and short away!
This will be fun to watch
New Blog Post
Again the 95% of the market pops up.
No pr since March mentions the word recurrent.
The label is now expanded to cover all melanoma except metastatic.
It will be now 95%-98% of all the melanoma indications.
Time to redo valuation models.
They will no longer be using the word recurrent just to give you a hint.
Press Release....Read Again.
Anybody see a word missing? Label has been expanded.
Due attention
Let's look at that......I have my own theories and base them on observations, conversations and my own thoughts.....
Think of a small mouse in a jungle of big cats..... Pvct wanted to go unnoticed I think for a period of time. They went undetected while they got patents on combinations with the other drug companies. I'm sure there are many other examples of deliberate stealth.
You need to be on a big exchange to gain the respect or access to bigger markets where publicity would follow.
You need to be a big Pharma with multi million dollar marketing budgets.
The company is from Knoxville TN not Boston, LA or Chicago.
You need to not work so well with at least a few side effects because that is every other drug ever.... How can a "cancer drug" not make you sick and work that well.... It goes against the grain.
You need more peer reviews in journals.... The problem with that is most are pay to publish under the table. An Amgen study on peer review papers found that most were irreproducible junk.... Complete garbage.... It's a tainted industry by their vetting.
You cannot be a commercial scientist in a world of academics....they will ridicule your work or ignore it until your able to shove your success up their ass......an event I am looking forward to watching on the sidelines.....GO US!
Very soon the timing will be right to blow the lid off everything Pvct and the world will know and be dumbfounded.
PV-10 cheaper, less toxic, more effective, easier to mfg and will be the one the insurance will pay for.
There is no concern.
I have heard due to the publicity from AF we now have north of 14,000 shareholders....but this number has not been confirmed.
There are thousands of shareholders....thousands meaning plural
Eric exercises more stock
640,000 more shares...he is loading up!
News section of the Blog.
BTD APP SUBMITTED!
The new board member has joined because his company is interested in the end game. Welcome to the beginning of the bidding wars.
The Order of Things
I want to see to maximize share price. This is my opinion and no one elses. To me these are the big event share price movers. Did I leave anything out?
1. BTD Application
2. China Deal
3. Nasdaq Uplisting
4. BTD Granted
5. India Deal
6. NDA
7. Big Pharma comes to the orphanage and picks us
8. Big bank sets fair market value
9. Other big pharmas come in and a bidding war starts
10. End Game Less
Hounddogg and Kid2......please make sure you call him today and ask your hard questions.
You should call Craig up about this....but I will say what he told me. If by some small chance it does not get BTD then they proceed to PIII/SPA which the format was already agreed to. Now considering what the comparator drugs is (I have forgotten what he said) the trial would only last 30 days. This is because the FDA takes a peek into the trial after 30 days and if there is a big improvement using PV-10 (and they know it would be) the trial shuts down early and PV-10 is approved on the spot. They already have the money to do it if need be...over 18mm in the bank....cost of PIII no more than 12mm. I asked is there any bad scenarios? None he said...it's all good routes.
To verify my post call PVCT: 1(866)998-0005
wade through the phone system until you get to the point where you have to enter the first three letters of Craig's name. It will route you to his cell phone if he is out. If you do not get through then he is on the phone and try later. He is taking calls today.
New Blog Post Up
His take on the Moffitt abstract
New AACR Abstract is out.
It's on the blog
The other drugs are winning the PR war for sure. Some of that is intentional on PVCT's part. Much flying under the radar was done until such time as the mouse could stand up to the lions. All the combination patents needed to be filed. We will now see more visibility now that's done.
I think he meant $4 plus
A must read in the news section on the blog.
Somebody correct me if I am wrong but I think Canada allows short selling of OTC.
New liver site opens per the news under the Blog
To be honest....I am concerned with out of the blue PR. It happened last time with the bear raid.....everybody be on your toes and your heads on a swivel.
And yes PR does help.....the real pr should be soon.
I am expecting the real deal to be announced soon though.
That pr was not PVCT generated nor initiated by PVCT...just someone throwing something out there to sell their report.
Front end vs back end loading deal negotiations. Waiting to consumate a deal based on BTD gives leverage to front end loading. Total deal could be worth around a billion with front end payment, hurdle payments and royalties. Then you have multi pharmas in the running. On top of that you have to work with the Chinese government's FDA. Several factors are in play but it looks like things are wrapping up.
Moffitt to Present PV-10 at AACR
It's on the blog.
The company will submit the btd application
Then it goes into the FDA mail room
Once the FDA pulls it from the mail room they will notify Pvct
Then the clock starts and Pvct will pr that moment I have been told
Not at this time
One foot first
Not at this time
Give the guy a cookie
26 patents are not for nothing!
I think pharmas are combining with each other in lower doses each to reduce their side effects each drug does. In the hopes that the combined therapy produces results with lower side effects.